[1] Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptorbinding[J]. Lancet, 2020, 395(10224):565-574.
[2] Hoffmann M, Weber H, Krueger N, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [EB/OL]. bioRxiv preprint, 2020. doi:https://doi.org/10.1101/2020.01.31.929042.
[3] Zhu N, Zhang D, Wang W L, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8):727-733.
[4] Chan J, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [J]. Lancet, 2020, 395(10223):514-523.
[5] Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020. doi:10.1038/s41586-020-2012-7.[Published online First: 2020/02/03].
[6] Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients[J]. N Engl J Med, 2020. doi:10.1056/NEJMc 2001737.[Published online February 19, 2020].
[7] Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China [J].Nature 2020. doi:10.1038/s41586-020-2008-3. [published online First: 2020/02/03]
[8] Wang C, Hornby P, Hayden G, et al. A novel coronavirus outbreak of global heath concern [J]. Lancet, 2020, 395(10223):470-473.
[9] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223):507-513.
[10] Paules C, Marston H, Fauci A, et al. Coronavirus infections-more than just the common cold[J]. JAMA, 2020. doi:10.100/jama.2020.0757.[Published online First: 2020/01/23]
[11] Mahase E. China corovirus: what do we know so far ? [J]. BMJ, 2020, 368. doi:10.1136/bmj.m308[published online First: 2020/01/24]
[12] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
[13] Cohen J. Wuhan seafood market may not be source of novel virus spreading globally [EB/OL]. (2020-01-26). https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreadi ng-globally.
[14] Guo Q, Li M, Wang C, et al. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm[J/OL]. bioRxiv preprint, 2020. https://www.biorxiv.org/content/10.1101/2020.01.21.914044v3. doi:10.1101/2020.01.21.914044.
[15] Lam T, Shum M, Zhu H, et al. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China [EB/OL]. bioRxiv preprint, 2020.https://www.biorxiv.org/content/10.1101/2020.02.13.945485v1. doi:10.1101/2020.02.13.945485.
[16] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学学杂志,2020,41(2):145-148.
[17] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection China[EB/OL]. medRxiv preprint 2020. doi:http//dx. doi.org/10.1101./2020.02.06.20020974.
[18] Chen H, Guo J, Wang C, et al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant woman: a retropeciive review of medical records[J]. Lancet, doi: https://doi.org/10.1016/S0140-6736(20)30360-3.[Published online First: 2020/02/12]
[19] Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection[J]. J Med Virol, doi: https://doi.org/10.1002/jmv.25725.[Published online First: 2020/0226]
[20] Zhou Y, Zeng Y, Tong Y, et al. Ophtalmologic evidence against the interpersonal transmission of 2019 novel coronovirus through conjunctiva[EB/OL]. medRxiv preprint 2020. http://doi.org/10.1101/2020.02.11.20021956.
[21] Wu Z, Mcgoogan J. Characteristics of and important lessons from the coronavirus disease 2019(COVID-19) outbreak in China [J]. JAMA, 2020. doi:10.1001/jama.2020.2648.[Published online First: 2020/02/24]
[22] Chang D, Lin M, Wei L, et al. Epidemiologic and clinical characteristics of novel coronavirus infections in 13 patients outside Wuhan, China[J]. JAMA, 2020. doi:10.1001/jama.2020.1623.[Published online First: 2020/02/07]
[23] Wang D, Hu B, Hu C, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA 2020. doi:10.1001/jama.2020.1585.[Published online First: 2020/02/07]
[24] Yang Y, Lu Q, Liu M, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China[EB/OL]. medRxiv preprint 2020. doi:http://doi.org/10.1101/2020.02.10.20021675.
[25] 刘 敏, 贺 鹏, 刘辉国, 等. 30例医务人员新型冠状病毒肺炎的临床特征分析[J]. 中华结核和呼吸杂志, 2020, 43:E016.
[26] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan China of novel coronavirus-infected pneumonia [J]. N Engl J Med, 2020. doi:10.1056/NEJMoa 2001316.[published online first: 2020/01/29].
[27] Tang B, Wang X, Li Q, et al. Estimation of the transmission risk of 2019-nCoV and its implication for public health interventions [EB/OL]. https://ssrn.com/abstract=3525558.
[28] Read J, Bridgen J, Cummings D, et al. Novel coronavirus 2019-nCoV:early estimation of epidemiological parameters and epidemicpredictions [EB/OL]. medrxiv preprint 2020. doi: https://doi.org/10.1101/2020.01.23.20018549.
[29] Tian H, Li Y, Liu Y, et al. Early evaluation of the Wuhan City travel restrictions in response to the 2019 novel coronavirus outbreak [EB/OL]. MedRxiv preprint 2020. doi: https://doi.org/10.1101/2020.01.30.20019844
[30] Mizumoto K, Kagaya K, Chowell G, et al.Early epidemiological assessment of the transmission potential and virulence of 2019-Novel Coronavirus in Wuhan City: China, 2019-2020[EB/OL]. medRxiv preprint 2020. https:/doi.org/ 10.1101/2020.02.12.20022434.